Belgian company Kwarts has won the trust of several investors for its AI-driven customer data platform A-Inside, which mainly focuses on companies in life sciences. The round totals €1.2 million, and had the participation of Volta Ventures, Imec.istart, BlueHealth Innovation Fund, LRM, Belfius and experienced business angels Jean-Marie Vliegen, Wouter Reggers and Wim Van Cappellen. The fresh funds will make it possible for Kwarts to recruit new data-minded talent.
“The combination of industry experience, the scientific foundation as well as the co-created approach with customers strengthens our confidence in a successful go-to-market strategy for Kwarts,” said Koen De Waele, Venture Partner at Volta Ventures. “The A-Inside platform will seamlessly add intelligence and insight to existing CRM systems in the life sciences sector.”
The A-Inside platform was developed within the framework of a VLAIO project in cooperation with the BIARU cell at Hasselt University and is based on scientific research. Moreover, Bart and Ruben each have ten years of experience in life sciences. CEO Bart Van Proeyen explained: “We approach the industry with expertise. Because of that background knowledge, there is an affinity for life sciences. Therefore, we work mainly with and for companies within the pharmaceutical and biotech sectors, both in Belgium and abroad. From our experience, we can come up with pragmatic solutions that work for our clients. But A-Inside is an agnostic platform, which means it can be perfectly implemented in other sectors”.
Kwarts has already completed projects in Europe and Asia, and has a trade mission to the US planned. To anticipate the expected growth, the company is expanding further. “With the current seven-person team, we are very strong in the field of AI. We are now looking for strong profiles in software development and data science, on top of commercial profiles. Together with them, we want to make Kwarts grow further and become a household name,” CCO Ruben De Moor of Kwarts concluded.
